Requisite Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$324K Sell
920
-11
-1% -$3.92K 0.06% 76
2025
Q4
$305K Buy
+931
New +$295K 0.06% 91
2025
Q3
Sell
-978
Closed -$273K 364
2025
Q2
$273K Buy
978
+18
+2% +$5.1K 0.06% 71
2025
Q1
$299K Sell
960
-171
-15% -$50.5K 0.07% 63
2024
Q4
$295K Sell
1,131
-100
-8% -$29.7K 0.06% 77
2024
Q3
$397K Buy
1,231
+231
+23% +$75.6K 0.08% 51
2024
Q2
$312K Hold
1,000
0.07% 63
2024
Q1
$284K Hold
1,000
0.06% 69
2023
Q4
$288K Sell
1,000
-428
-30% -$117K 0.07% 53
2023
Q3
$384K Buy
+1,428
New +$356K 0.1% 48

Other funds holding AMGN

Requisite Capital Management's AMGN Position: Q1 2026 in Review

Requisite Capital Management reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $3.92K and leaving 920 shares worth $324K. The position accounts for 0.06% of the portfolio, ranked #76.

Requisite Capital Management first reported a position in AMGN in Q3 2023 and has held it in 10 quarters since. The position peaked at $397K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Requisite Capital Management held 920 shares of Amgen worth $324K as of Q1 2026.
  • Requisite Capital Management sold 11 Amgen shares in Q1 2026, an estimated $3.92K.
  • Amgen made up 0.06% of Requisite Capital Management's portfolio in Q1 2026, its #76 holding.
  • Requisite Capital Management first reported a position in Amgen in Q3 2023 and has held it in 10 quarters since.
  • Requisite Capital Management's Amgen position peaked at $397K in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Requisite Capital Management's 13F filing for Q1 2026, filed 14 May 2026.